Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma
US patent 5,780,481
Press Enter · cited answer in seconds
0 sources
Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma
Summary
Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma is a patent[1].
Key Facts
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma is credited with the discovery of Richard Arthur Norton[2].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's image is recorded as United States patent 5780481.png[3].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's instance of is recorded as patent[4].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's publication date is recorded as +1996-08-08T00:00:00Z[5].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's main subject is recorded as adenosine[6].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's main subject is recorded as asthma[7].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's work available at URL is recorded as https://books.google.com/books?id=EyJ54tihg4kC&pg=PA1838[8].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's patent number is recorded as US5780481[9].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's different from is recorded as 2,6-Diaryl Pyridazinones With Immunosuppressant Activity[10].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's author name string is recorded as Marlene A. Jacobsen[11].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's author name string is recorded as Richard Arthur Norton[12].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's author name string is recorded as Prasun K. Chakravarty[13].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's quotation or excerpt is recorded as The invention is a method for inhibiting activation of the human A3 adenosine receptor with adenosine, by treating the receptor a compound of the formula ... to treat asthma.[14].
- Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's Lens ID is recorded as 083-650-117-787-288[15].
Body
Designation and Status
Method For Inhibiting Activation Of The Human A3 Adenosine Receptor To Treat Asthma's instance of is recorded as patent[4].